BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9279750)

  • 1. Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36.
    Williamson C; Pannett AA; Pang JT; Wooding C; McCarthy M; Sheppard MN; Monson J; Clayton RN; Thakker RV
    J Med Genet; 1997 Aug; 34(8):617-9. PubMed ID: 9279750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
    Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible tumor suppressor gene for parathyroid adenomas.
    Iwasaki H
    Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13.
    Chakrabarti R; Srivatsan ES; Wood TF; Eubanks PJ; Ebrahimi SA; Gatti RA; Passaro E; Sawicki MP
    Genes Chromosomes Cancer; 1998 Jun; 22(2):130-7. PubMed ID: 9598800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
    Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
    Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus.
    Eubanks PJ; Sawicki MP; Samara GJ; Wan YJ; Gatti RA; Hurwitz M; Passaro E
    Am J Surg; 1997 Jun; 173(6):518-20. PubMed ID: 9207166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
    Emmert-Buck MR; Lubensky IA; Dong Q; Manickam P; Guru SC; Kester MB; Olufemi SE; Agarwal S; Burns AL; Spiegel AM; Collins FS; Marx SJ; Zhuang Z; Liotta LA; Chandrasekharappa SC; Debelenko LV
    Cancer Res; 1997 May; 57(10):1855-8. PubMed ID: 9157974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
    Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
    Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
    Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
    Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
    Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.
    Lubensky IA; Debelenko LV; Zhuang Z; Emmert-Buck MR; Dong Q; Chandrasekharappa S; Guru SC; Manickam P; Olufemi SE; Marx SJ; Spiegel AM; Collins FS; Liotta LA
    Cancer Res; 1996 Nov; 56(22):5272-8. PubMed ID: 8912868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma.
    Leonard JH; Cook AL; Nancarrow D; Hayward N; Van Gele M; Van Roy N; Speleman F
    Cancer Detect Prev; 2000; 24(6):620-7. PubMed ID: 11198276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
    Dong Q; Debelenko LV; Chandrasekharappa SC; Emmert-Buck MR; Zhuang Z; Guru SC; Manickam P; Skarulis M; Lubensky IA; Liotta LA; Collins FS; Marx SJ; Spiegel AM
    J Clin Endocrinol Metab; 1997 May; 82(5):1416-20. PubMed ID: 9141526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.
    Cryns VL; Yi SM; Tahara H; Gaz RD; Arnold A
    Genes Chromosomes Cancer; 1995 May; 13(1):9-17. PubMed ID: 7541648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.
    Kjellman M; Roshani L; Teh BT; Kallioniemi OP; Höög A; Gray S; Farnebo LO; Holst M; Bäckdahl M; Larsson C
    J Clin Endocrinol Metab; 1999 Feb; 84(2):730-5. PubMed ID: 10022445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
    Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
    J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.